Lv11
70 积分 2025-07-21 加入
Guselkumab in Patients With Moderately to Severely Active Ulcerative Colitis: QUASAR Phase 2b Induction Study
7小时前
已完结
Guselkumab: A New Therapeutic Option for the Treatment of Moderately to Severely Active Ulcerative Colitis
7小时前
已完结
The Safety and Efficacy of Guselkumab for the Treatment of Moderate to Severely Active Ulcerative Colitis
8小时前
已完结
Guselkumab (Tremfya) for Ulcerative Colitis
8小时前
求助中
Efficacy and Safety of Guselkumab for Ulcerative Colitis Through Week 92 of the QUASAR Long-Term Extension Study
10小时前
已完结
皖公网安备34019202002308
